The Coronary Artery Disease Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the Coronary Artery Disease Global Market Report 2024 has seen significant growth in the past. The market, valued at $29.15 billion in 2024, is predicted to increase to $31.97 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.7%.
The Coronary Artery Disease Global Market Report 2024 projections for 2029 expect the market size to reach $48.48 billion, growing at a compound annual growth rate of 11.0%.
Download Your Free Sample of the 2025 Coronary Artery Disease Market Report and Uncover Key Trends Now!The key drivers in the coronary artery disease market are:
• Increasing lifestyle factors contributing to coronary artery disease
• Focus on telemedicine and remote monitoring
• Expansion of interventional cardiology procedures
• Shift towards value-based healthcare models and development of novel drug therapies.
The coronary artery disease market covered in this report is segmented –
1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments
2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Channels
4) By End-User: Hospitals, Specialty Clinics, Other End-Users
The key trends in the coronary artery disease market are:
• The development of gene therapies is emerging as a key trend.
• The integration of artificial intelligence in diagnosis is becoming increasingly important.
• There is growing focus on mental health as part of coronary artery disease care.
• The rise of home-based healthcare services and remote cardiac rehabilitation are significant trends.
The major players in the coronary artery disease market are:
• Pfizer Inc
North America was the largest region in the coronary artery disease market in 2024